A study published last year in an imprint of the Journal of the American Medical Association evaluated the relationship between U.S. legalization laws and psychosis rates in more than 63 million privately insured individuals. Researchers described it as the “largest [study] to quantify the association of medical and recreational cannabis policies with rates of psychosis-related health care claims across US states.”
The results showed that State medical and recreational cannabis policies were not associated with a statistically significant increase in rates of psychosis-related health outcomes.
Also, subsequent data from Canada published this month determined that cannabis-related emergency department visits declined among schizophrenia patients following Canada’s adoption of adult-use marijuana legalization. “Our findings suggest that regulatory measures accompanying legalization could enhance the quality and safety of cannabis products, potentially leading to fewer adverse health outcomes in vulnerable patient populations,” the study’s authors wrote. While one should still contact a medical professional if they have any questions, the data debunks the belief that cannabis can positively impact or cause no issues with one’s mental health.
